Current Rheumatology Reports

, 10:371

Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review



The high-range estimate of 1.3% by the National Arthritis Data Workgroup for the prevalence of the entire spectrum of spondyloarthropathies (SpAs) suggests that SpAs may be more prevalent than rheumatoid arthritis (RA) in the United States. Recent surveys from many European countries using the same sample population have also found SpA to be at least as common as RA in most of the studied populations, including Finnish, Swedish, Lithuanian, French, Italian, and Turkish. Among Asian populations, China has the highest prevalence of SpA, with reported estimates generally higher than that of RA. In Thailand and Vietnam, the two diseases are probably equally common, whereas RA seems to be more prevalent than SpA in the rest of Asia, the Pacific Region, and Latin America, as indicated by studies following the COPCORD (Community-Oriented Program for the Control of Rheumatic Diseases) protocol. Both rheumatic disorders are rare in Africa, but SpA is less common than RA.

References and Recommended Reading

  1. 1.
    Zink A, Braun J, Listing J, Wollenhaupt J: Disability and handicap in rheumatoid arthritis and ankylosing spondylitis—results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000, 27:613–622.PubMedGoogle Scholar
  2. 2.
    Akkoc N, Khan MA: Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In: Ankylosing Spondylitis and the Spondyloarthropathies. Edited by Weisman MH, Reveille JD, van der Heijde D. St. Louis: Mosby; 2006: 117–131.Google Scholar
  3. 3.
    Alamanos Y, Drosos AA: Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005, 4:130–136.PubMedCrossRefGoogle Scholar
  4. 4.
    Alamanos Y, Voulgari PV, Drosos AA: Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006, 36:182–188.PubMedCrossRefGoogle Scholar
  5. 5.
    Silman A: Rheumatoid arthritis. In: Epidemiology of the Rheumatic Diseases, 2 edn. Edited by Silman A. New York: Oxford University Press; 2001: 31–71.Google Scholar
  6. 6.
    Helmick CG, Felson DT, Lawrence RC, et al.: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States.Part I. Arthritis Rheum 2008, 58:15–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaipiainen-Seppanen O, Aho K: Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol 2000, 27:94–100.PubMedGoogle Scholar
  8. 8.
    Savolainen E, Kaipiainen-Seppanen O, Kroger L, Luosujarvi R: Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003, 30:2460–2468.PubMedGoogle Scholar
  9. 9.
    Soderlin MK, Borjesson O, Kautiainen H, et al.: Annual incidence of inflammatory joint diseases in a population-based study in southern Sweden. Ann Rheum Dis 2002, 61:911–915.PubMedCrossRefGoogle Scholar
  10. 10.
    Akkoc N, Khan MA: Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al. Arthritis Rheum 2005, 52:4048–4049; author reply 4049–4050.PubMedCrossRefGoogle Scholar
  11. 11.
    Steven MM: Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis 1992, 51:186–194.PubMedCrossRefGoogle Scholar
  12. 12.
    Braun J, Bollow M, Remlinger G, et al.: Prevalence of spondylarthropathies in HLA-B27 positive and negative bld donors. Arthritis Rheum 1998, 41:58–67 (Comment in Arthritis Rheum 2005, 52:4048–4049; author reply 4049–4050).PubMedCrossRefGoogle Scholar
  13. 13.
    Saraux A, Guedes C, Allain J, et al.: Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l’Ouest. J Rheumatol 1999, 26:2622–2627.PubMedGoogle Scholar
  14. 14.
    Andrianakos A, Trontzas P, Christoyannis F, et al.: Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol 2003, 30:1589–1601.PubMedGoogle Scholar
  15. 15.
    Saraux A, Guillemin F, Guggenbuhl P, et al.: Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 2005, 64:1431–1435.PubMedCrossRefGoogle Scholar
  16. 16.
    De Angelis R, Salaffi F, Grassi W: Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol 2007, 36:14–21.PubMedCrossRefGoogle Scholar
  17. 17.
    Onen F, Akar S, Birlik M, et al.: Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 2008, 35:305–309.PubMedGoogle Scholar
  18. 18.
    Adomaviciute D, Pileckyte M, Baranauskaite A, et al.: Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania. Scand J Rheumatol 2008, 37:113–119.PubMedCrossRefGoogle Scholar
  19. 19.
    Salaffi F, De Angelis R, Grassi W: Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005, 23:819–828.PubMedGoogle Scholar
  20. 20.
    Akar S, Birlik M, Gurler O, et al.: The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 2004, 22:416–420.PubMedGoogle Scholar
  21. 21.
    Andrianakos A, Trontzas P, Christoyannis F, et al.: Prevalence and management of rheumatoid arthritis in the general population of Greece—the ESORDIG study. Rheumatology (Oxford) 2006, 45:1549–1554.CrossRefGoogle Scholar
  22. 22.
    Trontzas P, Andrianakos A, Miyakis S, et al.: Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clinical Rheum 2005, 24:583–589.CrossRefGoogle Scholar
  23. 23.
    Guillemin F, Saraux A, Guggenbuhl P, et al.: Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005, 64:1427–1430.PubMedCrossRefGoogle Scholar
  24. 24.
    Roux CH, Saraux A, Le Bihan E, et al.: Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol 2007, 34:117–122.PubMedGoogle Scholar
  25. 25.
    Rendine S, Borelli I, Barbanti M, et al.: HLA polymorphisms in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998, 52:135–146.PubMedGoogle Scholar
  26. 26.
    Piazza A, Cerutti N, Di Gaetano C, et al.: Origin of the Etruscans: novel clues from the Y chromosome lineages [abstract 17]. Presented at the 39th European Human Genetics Conference. Nice, France; June 16–19, 2007.Google Scholar
  27. 27.
    Berkman CC, Dinc H, Sekeryapan C, Togan I: Alu insertion polymorphisms and an assessment of the genetic contribution of Central Asia to Anatolia with respect to the Balkans. Am J Phys Anthropol 2008, 136:11–18.PubMedCrossRefGoogle Scholar
  28. 28.
    Calafell F, Underhill P, Tolun A, et al.: From Asia to Europe: mitochondrial DNA sequence variability in Bulgarians and Turks. Ann Hum Genet 1996, 60:35–49.PubMedCrossRefGoogle Scholar
  29. 29.
    Shichikawa K, Inoue K, Hirota S, et al.: Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965–1996. Ann Rheum Dis 1999, 58:751–756.PubMedCrossRefGoogle Scholar
  30. 30.
    Muirden KD: The origins, evolution and future of COPCORD. APLAR J Rheumatol 1997, 1:44–48.Google Scholar
  31. 31.
    Chopra A: The WHO-ILAR COPCORD Bhigwan (India) model: foundation for a future COPCORD design and data repository. Clin Rheumatol 2006, 25:443–447.PubMedCrossRefGoogle Scholar
  32. 32.
    Zeng QY, Chen R, Darmawan J, et al.: Rheumatic diseases in China. Arthritis Res Ther 2008, 10:R17.PubMedCrossRefGoogle Scholar
  33. 33.
    Ng SC, Liao Z, Yu DT et al.: Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary. Semin Arthritis Rheum 2007, 37:39–47.PubMedCrossRefGoogle Scholar
  34. 34.
    Chou CT, Pei L, Chang DM, et al.: Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994, 21:302–306.PubMedGoogle Scholar
  35. 35.
    Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P: Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community Oriented Programme for the Control of Rheumatic Disease. J Rheumatol 1998, 25:1382–1387.PubMedGoogle Scholar
  36. 36.
    Hoa TTM, Damarwan J, Le CS, et al.: Prevalence of the rheumatic diseases in urban Vietnam: A WHO-ILAR COPCORD study. J Rheumatol 2003, 30:2252–2256.Google Scholar
  37. 37.
    Darmawan J, Valkenburg HA, Muirden KD, Wigley RD: Epidemiology of rheumatic diseases in rural and urban populations in Indonesia: a World Health Organisation International League Against Rheumatism COPCORD study, stage I, phase 2. Ann Rheum Dis 1992, 51:525–528.PubMedCrossRefGoogle Scholar
  38. 38.
    Darmawan J, Muirden KD, Valkenburg HA, Wigley RD: The epidemiology of rheumatoid arthritis in Indonesia. Br J Rheumatol 1993, 32:537–540.PubMedCrossRefGoogle Scholar
  39. 39.
    Veerapen K, Wigley RD, Valkenburg H: Musculoskeletal pain in Malaysia: a COPCORD survey. J Rheumatol 2007, 34:207–213.PubMedGoogle Scholar
  40. 40.
    Dans LF, Tankeh-Torres S, Amante CM, Penserga EG: The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD Study. World Health Organization. International League of Associations for Rheumatology. Community Oriented Programme for the Control of the Rheumatic Diseases. J Rheumatol 1997, 24:1814–1819.PubMedGoogle Scholar
  41. 41.
    Farqi A, Gibson T: Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol 1998, 37:491–495.CrossRefGoogle Scholar
  42. 42.
    Haq SA, Darmawan J, Islam MN, et al.: Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 2005, 32:348–353.PubMedGoogle Scholar
  43. 43.
    Chopra A, Patil J, Billempelly V, et al.: Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India 2001, 49:240–246.PubMedGoogle Scholar
  44. 44.
    Davatchi F, Jamshidi AR, Banihashemi AT, et al.: WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 2008, 35:1384.PubMedGoogle Scholar
  45. 45.
    Mathieu A, Cauli A, Fiorillo MT, Sorrentino R: HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis. Autoimmun Rev 2008, 7:398–403.PubMedCrossRefGoogle Scholar
  46. 46.
    Daniel-Ribeiro CT, Zanini G: Autoimmunity and malaria: what are they doing together? Acta Tropica 2000, 76:205–221.PubMedCrossRefGoogle Scholar
  47. 47.
    Senna ER, De Barros AL, Silva EO, et al.: Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004, 31:594–597.PubMedGoogle Scholar
  48. 48.
    Cardiel MH, Rojas-Serrano J: Community-based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheumatol 2002, 20:617–624.PubMedGoogle Scholar
  49. 49.
    Ferucci ED, Templin DW, Lanier AP: Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature. Semin Arthritis Rheum 2005, 34:662–667.PubMedCrossRefGoogle Scholar
  50. 50.
    Peschken CA, Esdaile JM: Rheumatic diseases in North America’s indigenous peoples. Semin Arthritis Rheum 1999, 28:368–391.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Division of Rheumatology and Immunology, Department of MedicineDokuz Eylul University Schl of MedicineIzmirTurkey

Personalised recommendations